Single-nucleotide polymorphism rs2070600 regulates AGER splicing and the sputum levels of the COPD biomarker soluble receptor for advanced glycation end-products.

Faiz, A; Rathnayake, SNH; Ten Hacken, NHT; Guryev, V; van den Berge, M; Pouwels, SD

Single-nucleotide polymorphism rs2070600 regulates AGER splicing and the sputum levels of the COPD biomarker soluble receptor for advanced glycation end-products.

Faiz, A

Rathnayake, SNH Ten Hacken, NHT Guryev, V van den Berge, M Pouwels, SD

Permalink

Publisher:: European Respiratory Society (ERS)
Publication Type:: Journal Article
Citation:: ERJ Open Res, 2021, 7, (2), pp. 00947-02020
Issue Date:: 2021-04

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download full textAdobe PDF (516.07 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Faiz, A https://orcid.org/0000-0003-1740-3538
dc.contributor.author	Rathnayake, SNH
dc.contributor.author	Ten Hacken, NHT
dc.contributor.author	Guryev, V
dc.contributor.author	van den Berge, M
dc.contributor.author	Pouwels, SD
dc.date.accessioned	2022-01-11T05:03:48Z
dc.date.available	2021-04-24
dc.date.available	2022-01-11T05:03:48Z
dc.date.issued	2021-04
dc.identifier.citation	ERJ Open Res, 2021, 7, (2), pp. 00947-02020
dc.identifier.issn	2312-0541
dc.identifier.issn	2312-0541
dc.identifier.uri	http://hdl.handle.net/10453/152908
dc.description.abstract	The COPD susceptibility SNP rs2070600 affects the levels of the COPD biomarker sRAGE in sputum as well as splicing of AGER. Moreover, @PouwelsScience et al. demonstrate large differences in sRAGE levels between serum and sputum. https://bit.ly/3t0pJtK.
dc.format	Electronic-eCollection
dc.language	eng
dc.publisher	European Respiratory Society (ERS)
dc.relation.ispartof	ERJ Open Res
dc.relation.isbasedon	10.1183/23120541.00947-2020
dc.rights	info:eu-repo/semantics/openAccess
dc.title	Single-nucleotide polymorphism rs2070600 regulates AGER splicing and the sputum levels of the COPD biomarker soluble receptor for advanced glycation end-products.
dc.type	Journal Article
utslib.citation.volume	7
utslib.location.activity	England
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Life Sciences
pubs.organisational-group	/University of Technology Sydney/Centre for Health Technologies (CHT)
utslib.copyright.status	open_access	*
dc.date.updated	2022-01-11T05:03:46Z
pubs.issue	2
pubs.publication-status	Published online
pubs.volume	7
utslib.citation.issue	2

Abstract:

The COPD susceptibility SNP rs2070600 affects the levels of the COPD biomarker sRAGE in sputum as well as splicing of AGER. Moreover, @PouwelsScience et al. demonstrate large differences in sRAGE levels between serum and sputum. https://bit.ly/3t0pJtK.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/152908